BlackRock
CDMO

BlackRock’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

BlackRock’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,262,221
Closed -$65M – 5561
2024
Q4 		$65M Buy
5,262,221
+3,022
+0.1% +$34.6K ﹤0.01% 2305
2024
Q3 		$59.8M Buy
5,259,199
+152,852
+3% +$1.53M ﹤0.01% 2365
2024
Q2 		$36.5M Sell
5,106,347
-69,375
-1% -$531K ﹤0.01% 2599
2024
Q1 		$34.7M Sell
5,175,722
-105,722
-2% -$727K ﹤0.01% 2661
2023
Q4 		$34.3M Sell
5,281,444
-4,391,516
-45% -$28.3M ﹤0.01% 2712
2023
Q3 		$91.3M Sell
9,672,960
-142,090
-1% -$1.71M ﹤0.01% 2045
2023
Q2 		$137M Buy
9,815,050
+102,467
+1% +$1.75M ﹤0.01% 1837
2023
Q1 		$182M Sell
9,712,583
-205,520
-2% -$3.38M 0.01% 1608
2022
Q4 		$137M Buy
9,918,103
+263,404
+3% +$4.03M ﹤0.01% 1800
2022
Q3 		$185M Buy
9,654,699
+141,894
+1% +$2.59M 0.01% 1538
2022
Q2 		$145M Sell
9,512,805
-168,708
-2% -$2.5M ﹤0.01% 1772
2022
Q1 		$197M Buy
9,681,513
+11,735
+0.1% +$239K 0.01% 1690
2021
Q4 		$282M Buy
9,669,778
+5,285,265
+121% +$151M 0.01% 1483
2021
Q3 		$94.6M Buy
4,384,513
+53,355
+1% +$1.29M ﹤0.01% 2255
2021
Q2 		$111M Buy
4,331,158
+163,912
+4% +$3.5M ﹤0.01% 2182
2021
Q1 		$76M Buy
4,167,246
+321,838
+8% +$5.35M ﹤0.01% 2353
2020
Q4 		$44.4M Buy
3,845,408
+10,592
+0.3% +$96.8K ﹤0.01% 2553
2020
Q3 		$29.2M Sell
3,834,816
-111,172
-3% -$842K ﹤0.01% 2643
2020
Q2 		$25.9M Buy
3,945,988
+64,467
+2% +$360K ﹤0.01% 2663
2020
Q1 		$19.8M Sell
3,881,521
-52,910
-1% -$320K ﹤0.01% 2607
2019
Q4 		$30.2M Buy
3,934,431
+8,905
+0.2% +$52K ﹤0.01% 2649
2019
Q3 		$20.8M Buy
3,925,526
+135,240
+4% +$840K ﹤0.01% 2796
2019
Q2 		$21.2M Buy
3,790,286
+266,015
+8% +$1.1M ﹤0.01% 2814
2019
Q1 		$15M Sell
3,524,271
-56,512
-2% -$231K ﹤0.01% 2903
2018
Q4 		$14.7M Buy
3,580,783
+3,834
+0.1% +$20K ﹤0.01% 2888
2018
Q3 		$24.5M Buy
3,576,949
+315,661
+10% +$1.87M ﹤0.01% 2751
2018
Q2 		$12.8M Buy
3,261,288
+2,502,164
+330% +$8.68M ﹤0.01% 3116
2018
Q1 		$2.22M Sell
759,124
-2,886
-0.4% -$8.92K ﹤0.01% 3655
2017
Q4 		$2.96M Buy
762,010
+708
+0.1% +$3.03K ﹤0.01% 3590
2017
Q3 		$2.39M Sell
761,302
-44,704
-6% -$168K ﹤0.01% 3662
2017
Q2 		$3.43M Sell
806,006
-49,431
-6% -$202K ﹤0.01% 3564
2017
Q1 		$3.92M Buy
+855,437
New +$2.87M ﹤0.01% 3458
2016
Q2 		– Sell
-4,535
Closed -$13K – 3839
2016
Q1 		$13K Buy
4,535
+3,905
+620% +$20.9K ﹤0.01% 3048
2015
Q4 		$5K Hold
630
– – ﹤0.01% 3169
2015
Q3 		$4K Hold
630
– – ﹤0.01% 3088
2015
Q2 		$6K Sell
630
-158
-20% -$1.52K ﹤0.01% 3084
2015
Q1 		$7K Hold
788
– – ﹤0.01% 2931
2014
Q4 		$8K Hold
788
– – ﹤0.01% 2900
2014
Q3 		$8K Buy
788
+191
+32% +$2.14K ﹤0.01% 2875
2014
Q2 		$8K Sell
597
-124
-17% -$1.56K ﹤0.01% 2947
2014
Q1 		$10K Hold
721
– – ﹤0.01% 2727
2013
Q4 		$7K Buy
721
+170
+31% +$1.6K ﹤0.01% 2938
2013
Q3 		$5K Hold
551
– – ﹤0.01% 3002
2013
Q2 		$5K Buy
+551
New +$5.78K ﹤0.01% 3035

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $426M AUM 23.62% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BlackRock's CDMO Position: Q1 2025 in Review

BlackRock sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 5,262,221 shares — an estimated $65M sold.

BlackRock first reported a position in CDMO in Q2 2013 and held it in 44 quarters. The position peaked at $282M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • BlackRock reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • BlackRock sold 5,262,221 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $65M.
  • BlackRock first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 44 quarters.
  • BlackRock's Avid Bioservices, Inc. Common Stock position peaked at $282M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on BlackRock's 13F filing for Q1 2025, filed 2 May 2025.